Menu

Glioma Prognostic Subtyping

Renal Cell Carcinoma (RCC) Classification - ccRCC, pRCC, and chRCC using New miRNA Biomarker Panel Ready-to-Use fully optimized SSNA miRNA In Situ Hybridization (ISH) Kit Renal cell carcinoma (RCC) consists of an array of morphologically and genetically distinct...

read more

Renal Cell Carcinoma (RCC) Classification

Renal Cell Carcinoma (RCC) Classification - ccRCC, pRCC, and chRCC using New miRNA Biomarker Panel Ready-to-Use fully optimized SSNA miRNA In Situ Hybridization (ISH) Kit Renal cell carcinoma (RCC) consists of an array of morphologically and genetically distinct...

read more

miRNA-ISH for Cancer of Unknown Primary

miRNA-ISH for Cancer of Unknown Primary Summary: World-wide approximately 5% of all cancers are determined to have an occult or unknown primary location, upon initial assessment, prior to completing a full pathology report. [Oien] Unfortunately in 20-50% of CUP cases...

read more

MicroRNA in situ Hybridization for Cancer Diagnosis

MicroRNA in situ hybridization for cancer diagnosis Summary: MicroRNAs (miRNA) are approximately 19–24 nucleotides in length and base-pair to complementary sites within messenger RNA (mRNA). Aided by the “RISC” complex this binding functions to promote down-regulation...

read more

Fluorescent in situ Hybridization (FISH) – Made Easy

We are pleased to introduce the BioGenex eFISH system. This system consist of high specificity eFISH probes, visualization kits, ancillary reagents, in addition to our brand new automated systems: Xmatrx® NANO, and NanoVIP, and our manual system Xmatrx® MINI. This...

read more

FISH: Applications in Cancer Diagnostics

Application in different cancers – towards personalized medicine! Cancer is particularly suitable to FISH evaluation and analysis as the genetic defects uncovered by FISH represents early genetic triggers or events responsible for cancer at stem-cell level. FISH is...

read more